RNS Number : 8490X Renalytix PLC 10 January 2022 Renalytix plc ("Renalytix" or the "Company") Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved
RNS Number : 7098X Renalytix PLC 07 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Appoints Jean M. Casner as Chief Human Resources Officer NEW YORK, NY and SALT LAKE CITY, UT January 7, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.
RNS Number : 4318X Renalytix PLC 05 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company
RNS Number : 2538X Renalytix PLC 04 January 2022 Renalytix plc ("Renalytix" or the "Company") American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population National program establishes early care management, technology innovation and large
RNS Number : 0925W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Result of AGM LONDON and SALT LAKE , 17 December 2021 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were
RNS Number : 0593W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000
RNS Number : 3617V Renalytix PLC 13 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of
RNS Number : 1070V Renalytix PLC 09 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of
RNS Number : 9024U Renalytix PLC 08 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
RNS Number : 7546U Renalytix PLC 07 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , December 7, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial